[The use of opiate receptor ligands for correction of heart electrical instability].
Lishmanov
Iu B
IuB
Krylatov
A V
AV
Naryzhnaia
N V
NV
Maslov
L N
LN
D000818:Animals; D001281:Atrial Fibrillation / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D006321:Heart / Q000187:drug effects* / Q000503:physiopathology; D007103:Immobilization; D008024:Ligands; D008297:Male; D009203:Myocardial Infarction / Q000150:complications; D009842:Oligopeptides / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology; D011759:Pyrrolidines / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011957:Receptors, Opioid / Q000187:drug effects*; D017473:Receptors, Opioid, kappa / Q000819:agonists; D017450:Receptors, Opioid, mu / Q000819:agonists; D017480:Receptors, sigma / Q000037:antagonists & inhibitors; D013312:Stress, Physiological / Q000150:complications
D008024:Ligands; D009842:Oligopeptides; D010880:Piperidines; D011759:Pyrrolidines; D011957:Receptors, Opioid; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu; D017480:Receptors, sigma; C063076:tyrosyl-arginyl-phenylalanyl-lysinamide; C078773:DuP 734; C051272:spiradoline
Ispol'zovanie ligandov opiatnykh retseptorov dlia korrektsii élektricheskoĭ nestabil'nosti serdtsa.